Showing results (61-70 of 99) with videos related to

Sort By:
Pageof 10
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1987
Molecular cloning and expression of hybridoma growth factor in Escherichia coliJ P Brakenhoff, E R de Groot, R F Evers, et al.
Journal of Molecular Biology|November 2, 1999
The variable region-1 from tissue-type plasminogen activator confers specificity for plasminogen activator inhibitor-1 to thrombin by facilitating catalysis: release of a kinetic block by a heterologous protein surface loopR J Dekker, A Eichinger, A A Stoop, et al.
Journal of Cellular Biochemistry|January 1, 1986
Structure and function of human tissue-type plasminogen activator (t-PA)A J van Zonneveld, H Veerman, M E MacDonald, et al.
Blood|September 18, 1997
The suicide substrate reaction between plasminogen activator inhibitor 1 and thrombin is regulated by the cofactors vitronectin and heparinM van Meijer, A Smilde, G Tans, et al.
Cardiovascular Research|October 31, 2001
Vascular calcification: expression patterns of the osteoblast-specific gene core binding factor alpha-1 and the protective factor matrix gla protein in human atherogenesisM A Engelse, J M Neele, A L Bronckers, et al.
Thrombosis and Haemostasis|March 1, 1997
The composition of complexes between plasminogen activator inhibitor 1, vitronectin and either thrombin or tissue-type plasminogen activatorM van Meijer, A Stoop, A Smilde, et al.
The Biochemical Journal|February 15, 1991
The pro-polypeptide of von Willebrand factor is required for the formation of a functional factor VIII-binding site on mature von Willebrand factorA Leyte, J Voorberg, H B Van Schijndel, et al.
The Journal of Biological Chemistry|December 25, 1987
Activation of human endothelial cell-type plasminogen activator inhibitor (PAI-1) by negatively charged phospholipidsJ W Lambers, M Cammenga, B W König, et al.
The Journal of Biological Chemistry|March 29, 1996
Selective screening of a large phage display library of plasminogen activator inhibitor 1 mutants to localize interaction sites with either thrombin or the variable region 1 of tissue-type plasminogen activatorM van Meijer, Y Roelofs, J Neels, et al.
Circulation|February 15, 1995
Thrombolysis and reocclusion in experimental jugular vein and coronary artery thrombosis. Effects of a plasminogen activator inhibitor type 1-neutralizing monoclonal antibodyB J Biemond, M Levi, R Coronel, et al.
Pageof 10